In this article, we review the use of AChEI's for the targeted treatment of visual hallucinations in schizophrenia.

Background: Visual hallucinations occur in various neurological diseases, but are most prominent in Lewy body dementia, Parkinson's disease and schizophrenia. The lifetime prevalence of visual ...